14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
VIOT vs CANG: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VIOT vs CANG. Trailing 12-month operating profitability (VIOT -2.4% vs CANG -11.1%) and valuation multiples (VIOT 7.3x vs CANG 3.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Capital Markets value chain with $60.7M market capitalization and -11.1% operating margin.
OpEx & R&D Reinvestment5.7% of Rev ($32M)
90D Engineering Disclosures0 Published
Investor FAQ VIOT vs CANG Key Questions & Quantitative Answers
As of Nov 19, 2026, Cango Inc. (CANG) is the stronger overall head-to-head candidate over Viomi Technology Co., Ltd (VIOT) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). VIOT carries a Unified Composite Score of 45.7/100 (HOLD) at $1.28 (7.3x Forward P/E, -2.4% operating margin), whereas CANG carries 51.3/100 (HOLD) at $1.64 (3.1x Forward P/E, -11.1% operating margin). Technically, VIOT sits in a Neutral phase (RSI 42.6, UNCLASSIFIED options structure) and CANG sits in a Neutral phase (RSI 49.5, UNCLASSIFIED options structure).
CANG leads the Growth & Scale pillar: VIOT posts -49.9% YoY revenue growth and -62.3% YoY earnings growth on $1.69B TTM revenue (23.8% gross margin, -2.4% operating margin), compared with CANG at -33.2% YoY revenue growth and +137.3% YoY earnings growth on $557M TTM revenue (-5.4% gross margin, -11.1% operating margin). On trailing 12-month operating scale, VIOT generates $1.69B in USD-normalized revenue versus $557M for CANG. In operating R&D and SG&A reinvestment, VIOT deploys 26.2% of Rev ($443M) (0 90-day corporate R&D disclosures) versus 5.7% of Rev ($32M) (0 disclosures) for CANG.
CANG screens cheaper on headline valuation multiples. VIOT trades at 7.3x Forward P/E, 7.3x Trailing P/E, 0.73x PEG, and N/M EV/Revenue (0.5% EBITDA margin), whereas CANG trades at 3.1x Forward P/E, 3.1x Trailing P/E, N/M PEG, and 0.2x EV/Revenue (12.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VIOT (-0.4% ROE) versus CANG (-151.0% ROE) capital efficiency.
In options market volatility and institutional positioning, VIOT carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.54β · 64% Vol realized risk). By comparison, CANG carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (8.01β · 222% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.